What's in Providence Therapeutics Holdings Inc.'s pipeline?

Providence Therapeutics Holdings Inc. has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Providence Therapeutics Holdings Inc.'s portfolio?

Top competitors by shared drug class: Arcturus Therapeutics, Inc., Assistance Publique - Hôpitaux de Paris, BioNTech SE, CSPC Megalith Biopharmaceutical Co.,Ltd., CanSino Biologics Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/providence-therapeutics-holdings-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Providence Therapeutics Holdings Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Providence Therapeutics Holdings Inc. pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
PTX-COVID19-B	PTX-COVID19-B	phase 3	mRNA vaccine	SARS-CoV-2 spike protein and additional viral antigens	Immunology / Infectious Disease

Therapeutic area mix

Immunology / Infectious Disease · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Arcturus Therapeutics, Inc. · 1 shared drug class
Assistance Publique - Hôpitaux de Paris · 1 shared drug class
BioNTech SE · 1 shared drug class
CSPC Megalith Biopharmaceutical Co.,Ltd. · 1 shared drug class
CanSino Biologics Inc. · 1 shared drug class
Clover Biopharmaceuticals AUS Pty · 1 shared drug class
Federal University of Espirito Santo · 1 shared drug class
AIM Vaccine Co., Ltd. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Providence Therapeutics Holdings Inc.:

Cite this brief

Drug Landscape (2026). Providence Therapeutics Holdings Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/providence-therapeutics-holdings-inc. Accessed 2026-05-17.